Skip Navigation

Phone Service Update

We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for people with urgent and acute medical care needs. Unfortunately, this means we are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Read more COVID-19 Vaccine Information

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Search Menu
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases

Sexually Transmitted Diseases: A Hidden Epidemic in the United States and Beyond

The State of STDs in the US - 2018

The need to develop sensitive, specific, and more easily available point-of-care (POC) technologies for diagnosing sexually transmitted diseases (STDs) is critical. Five of the top ten reportable diseases in the United States are STDs. CDC data indicate that in 2018 in the United States, a combined total of nearly 2.5 million new cases of chlamydia, gonorrhea, and syphilis were reported. The global incidence of four curable sexually transmitted diseases (chlamydia, gonorrhea, syphilis, and trichomoniasis) is estimated at over 357 million cases. Many cases go undiagnosed and untreated.

Young people (ages 15-24) are particularly affected, accounting for half of all new infections. Some of these sexually transmitted infections (STIs) have the potential to cause serious health problems, especially if not diagnosed and treated early. Stigma, privacy, and confidentiality issues make STDs/STIs optimal areas for point-of-care tests at healthcare facilities and for over-the-counter tests performed at home. 

Our Mission

At the Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases, our mission is to develop and test the accuracy, acceptability, and optimal implementation of point-of-care tests for sexually transmitted diseases in diverse care delivery contexts both in the United States and in resource-limited settings.

Located in the Division of Infectious Diseases of the Johns Hopkins University School of Medicine, the Center brings together a dedicated and experienced group of faculty and staff who are committed to stopping the epidemic of Sexually Transmitted Diseases. In addition to personnel from Johns Hopkins, the Center includes scientists and staff from the Cincinnati Children's Hospital Medical Center (CCHMC) and the Infectious Diseases Institute (IDI) in Kampala, Uganda. We are part of the Point-of-Care Technologies Research Network (POCTRN) which was created by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in 2007. We are funded through a grant from NIBIB.

News and Announcements

Partnership with the Baltimore City Health Department

August 3, 2020
Our Center and the Baltimore City Health Department have partnered to expand access to HIV and STI testing through I Want The Kit. Read more about the partnership.

Funding Opportunity for Technology Developers

April 2, 2020
Our 2020 tactical funding solicitation application period is closed. Check back in October 2020 for information about the 2021 solicitation. Read the 2020 solicitationView the 2020 revised solicitation timeline. (*Revised on April 29*)  

Mycoplasma genitalium and antimicrobial resistance

September 2019
Mycoplasma genitalium is more common than gonorrhea and has high levels of antimicrobial resistance. Read More.

New Chlamydia Test Delivers Results in About 30 Minutes

November 2018
Read More.

Developing Point of Care Tests for Sexually Transmitted Diseases: An Opportunity for Industry

Listen to what some experts say about the need for point-of-care testing for sexually transmitted diseases.